|
KMID : 0363620190400010153
|
|
Journal of Korean Oriental Medicine
2019 Volume.40 No. 1 p.153 ~ p.173
|
|
|
Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for Lung Cancer]
|
|
Han Ga-Jin
Cho Min-Ji
Park Eun-Joo
Seong Shin
Kim Sung-Su
Kim Kwan-Il
Jung Doo-Young
Lee Beom-Jun
Leem Jung-Tae
|
|
|
Abstract
|
|
|
Objectives: This study aimed to ascertain what should be considered in the “Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer” by analyzing the existing guidelines and clinical trials.
Methods: The committee searched guidelines and clinical trials about herbal medicine for lung cancer. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of our analysis with the guidelines to identify the issues we will have to consider when making the “Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer”. Several guidelines for anti-tumor agents and clinical trials with herbal medicine were searched on the national institution homepage. The search terms were as follows: ‘lung neoplasm’, ‘herbal medicine’, ‘Medicine, Korean traditional’, ‘Medicine, Chinese Traditional’ etc.
Results: There was no guideline for clinical trial with herbal medicine for lung cancer. In addition, 7 articles were searched through database searching. All the participants had non-small cell lung cancer. The type of intervention was decoction. Comparators included conventional treatments such as chemotherapy. The outcome measurements used in the studies were quality of life, tumor response, and survival duration, etc. Safety was evaluated by recording adverse events and blood test.
Conclusions: Findings were made by reviewing existing guidelines and comparing them with clinical trials for lung cancer and herbal medicinal products. These results will be utilized in the development of “Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer”.
|
|
|
KEYWORD
|
|
|
lung neoplasms, herbal medicinal product, clinical trial, guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|